“We Are Not Back to The Pre-COVID Market”: Upcoming Webinar
Bruce Carlson
Eye on IVD LLC. Former Head of Kalorama Information. Market Research Consultant and Publisher.
With the reduction of COVID-19 testing and as companies recover test sale revenues, there has been a tendency to say: we are back to 2019 levels. In an upcoming webinar this Wednesday, we will dispute this, and we will make the case that the in vitro diagnostic market for infectious diseases is not merely “back to the pre-COVID-19 era.”
60 attendees so far have signed up for the webinar, representing a wide range of functions and companies including IVD industry, entrepreneurs and consultants. Eye On IVD LLC has put a 100-attendee limit on the webinar, but slots are currently available:
While there has been a reduction in testing for COVID-19, particularly asymptomatic testing that characterized a few years ago, there are longer-term changes that make this new era different.
From installed bases to menu expansion, pandemic-based changes are fundamental, not passing. It is not 2019, as we will state in one of our many slides in the upcoming INFECTIOUS IVD TRENDS AND OPPORTUNITY WEBINAR on Wednesday, November 6th, 2024.
In terms of this era being fundamentally different from the pre-COVID era in the market, we note there are four reasons given for this situation:
CONTINUE READING ON EYE ON IVD.com